[1]李星欣,黎安茂,曾沉思,等.沉默NUPR1降低人多发性骨髓瘤U266细胞自噬并促进其迁移和侵袭[J].第三军医大学学报,2019,41(23):2322-2327.
 LI Xingxin,LI Anmao,ZENG Chensi,et al.Silencing NUPR1 down-regulates autophagy and promotes migration and invasion in human multiple myeloma U266 cells[J].J Third Mil Med Univ,2019,41(23):2322-2327.
点击复制

沉默NUPR1降低人多发性骨髓瘤U266细胞自噬并促进其迁移和侵袭(/HTML )
分享到:

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
41卷
期数:
2019年第23期
页码:
2322-2327
栏目:
基础医学
出版日期:
2019-12-15

文章信息/Info

Title:
Silencing NUPR1 down-regulates autophagy and promotes migration and invasion in human multiple myeloma U266 cells
作者:
李星欣黎安茂曾沉思陈建斌
400016 重庆,重庆医科大学附属第一医院血液内科
Author(s):
LI Xingxin LI Anmao ZENG Chensi CHEN Jianbin

Departments of Hematology, the First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China

关键词:
核蛋白1多发性骨髓瘤自噬迁移侵袭
Keywords:
nuclear protein 1 multiple myeloma autophagy migration invasion
分类号:
R73-37; R730.23; R733.3
文献标志码:
A
摘要:

目的探讨沉默核蛋白1(nuclear protein 1, NUPR1)对人多发性骨髓瘤细胞自噬、迁移和侵袭的影响及其机制。方法用含有NUPR1-shRNA慢病毒载体的病毒感染骨髓瘤U266细胞,通过流式细胞术检测转染效率,实验分为阴性对照组(转染无关序列shRNA慢病毒)和敲低组(转染NUPR1-shRNA慢病毒)。qRT-PCR检测NUPR1mRNA表达,Western blot检测NUPR1、自噬相关蛋白(LC3Ⅱ/LC3Ⅰ、Beclin1、ATG5和P62)、迁移和侵袭相关蛋白(MMP9、CXCR4)以及通路蛋白(p-AKT/T-AKT和p-mTOR/T-mTOR)的表达;透射电子显微镜(TEM)观察自噬小体;Transwell检测细胞迁移和侵袭能力。结果与阴性对照组比较,敲低组NUPR1 mRNA和蛋白表达显著下调(P<0.05),自噬相关蛋白ATG5、Beclin1和LC3Ⅱ/LC3Ⅰ的表达明显降低(P<0.05),而MMP9、CXCR4、P62、p-AKT/T-AKT和p-mTOR/T- mTOR蛋白表达明显增高(P<0.05);敲低组自噬小体明显减少,细胞迁移和侵袭能力增强,雷帕霉素可阻断该促进作用。结论沉默NUPR1可能通过降低自噬水平促进U266细胞迁移和侵袭,并可能与AKT/mTOR通路激活有关。

Abstract:

ObjectiveTo explore the effect of silencing nuclear protein 1 (NUPR1) on autophagy, migration and invasion in human multiple myeloma (MM) U266 cells and its possible mechanism. MethodsNUPR1-shRNA was transfected into MM U266 cells, and the transfection rate was detected by flow cytometry. Then the cells were divided into negative control cells (transfected with unrelated sequence RNA lentiviral vector) and NUPR1 knockdown cells (transfected with NUPR1-shRNA lentiviral vector). The interference effect of NUPR1 was detected by qRT-PCR, and the expression levels of autophagy related proteins (Beclin1, ATG5, LC3Ⅱ/LC3Ⅰ, P62), migration and invasion associated proteins (MMP9, CXCR4) and pathway proteins (p-AKT/T-AKT, p-mTOR/T-mTOR) were measured by Western blotting. Transmission electron microscopy (TEM) was used to observe autophagosomes. Transwell test was employed to detect cell migration and invasion. ResultsThe expression of NUPR1 at mRNA and protein level was significantly decreased in NUPR1 knockdown cells (P<0.05). The protein levels of autophagy related proteins, ATG5, Beclin1 and LC3Ⅱ/LC3Ⅰwere significantly lower, while those of f MMP9, CXCR4, P62,  p-AKT/T-AKT and p-mTOR/T-mTOR were increased obviously in the NUPR1 knockdown cells than the negative control cells (P<0.05). There were significantly reduced autophagosomes in NUPR1 knockdown cells. While, migratory and invasive abilities were enhanced in NUPR1 knock down group, and rapamycin reduced the promoting effects. ConclusionSilencing NUPR1 may promotes migration and invasion by down-regulating autophagy in U266 cells, which may be related to activation of the AKT/mTOR pathway.

参考文献/References:

[1]AL-HUJAILY E M, OLDHAM R A, HARI P, et al. Development of novel immunotherapies for multiple myeloma[J]. Int J Mol Sci, 2016, 17(9): E1506. DOI:10.3390/ijms17091506.
[2]BARWICK B G, GUPTA V A, VERTINO P M, et al. Cell of origin and genetic alterations in the pathogenesis of multiple myeloma[J]. Front Immunol, 2019, 10: 1121. DOI:10.3389/fimmu.2019.01121.
[3]YANAMANDRA U, KUMAR S K. Minimal residual disease analysis in myeloma-when, why and where[J]. Leuk Lymphoma, 2018, 59(8): 1772-1784. DOI:10.1080/10428194.2017.1386304.
[4]MATSUNAGA K, FUJISAWA K, TAKAMI T, et al. NUPR1 Acts as a pro-survival factor in human bone marrow-derived mesenchymal stem cells and is induced by the hypoxia mimetic reagent deferoxamine[J]. J Clin Biochem Nutr, 2019, 64(3): 209-216. DOI:10.3164/jcbn.18-112.
[5]TAN L, YAMMANI R R. Nupr1 regulates palmitate-induced apoptosis in human articular chondrocytes[J]. Biosci Rep, 2019, 39(2): BSR20181473. DOI:10.1042/BSR20181473.
[6]李丁. 转录调节因子NUPR1在相关疾病发生发展中的作用及其机制研究进展[J]. 山东医药, 2018,58(35): 111-114. DOI: 10.3969/j.issn.1002-266X.2018.35.031.
LI D. Advances in the role of transcriptional regulatory factor NUPR1 in the development of related diseases and its mechanism[J]. Shandong Med J, 2018, 58(35): 111-114. DOI: 10.3969/j.issn.1002-266X.2018.35.031.
[7]黄红艳, 张彦斌, 王小利, 等. 靶向敲低核蛋白1抑制HepG2肝癌细胞的增殖及迁移[J]. 细胞与分子免疫学杂志, 2015, 31(6): 782-786.
HUANG H Y, ZHANG Y B, WANG X L, et al. Nuclear protein 1 knockdown inhibits proliferation and migration of HepG2 cells[J]. Chin J Cell Mol Immunol, 2015, 31(6): 782-786.
[8]邓跃林, 陈艳丽, 吴华杰, 等. Nupr1调控非小细胞肺癌细胞迁移、凋亡机制的研究[J]. 现代生物医学进展, 2017, 17(19): 3636-3640. DOI:10.13241/j.cnki.pmb.2017.19.009.
DENG Y L, CHEN Y L, WU H J, et al. Nupr1 regulates the migration and apoptosis of non-small cell lung cancer cells[J]. Prog Mod Biomed, 2017, 17(19): 3636-3640. DOI:10.13241/j.cnki.pmb.2017.19.009.
[9]MU Y, YAN X, LI D, et al. NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells[J]. Autophagy, 2018, 14(4): 654-670. DOI: 10.1080/15548627.2017.1338556.
[10]WU H, LIU C, YANG Q, et al. MIR145-3p promotes autophagy and enhances bortezomib sensitivity in multiple myeloma by targeting HDAC4[J]. Autophagy, 2019,15(9): 1-15. DOI: 10.1080/15548627.2019.1635380.
[11]李星欣, 曾沉思, 杨泽松, 等. 沉默NUPR1基因对人多发性骨髓瘤U266细胞自噬的影响及机制研究[J]. 重庆医科大学学报, 2019, 44(2): 146-151.
LI X X, ZENG C S, YANG Z S, et al. Effect of silencing NUPR1 gene on autophagy in human multiple myeloma U266 cells and its mechanism[J]. J Chongqing Med Univ, 2019, 44(2): 146-151.
[12]ZENG C, LI X, LI A, et al. Knockdown of NUPR1 inhibits the growth of U266 and RPMI8226 multiple myeloma cell lines via activating PTEN and caspase activation-dependent apoptosis[J]. Oncol Rep, 2018, 40(3): 1487-1494. DOI: 10.3892/or.2018.6544.
[13]王纪珍,陈君敏,曾志勇,等.自噬调节药物对多发性骨髓瘤细胞增殖、凋亡和自噬的影响[J]. 中国实验血液学杂志, 2018, 26(3): 817-823. DOI:10.7534/j.issn.1009-2137.2018.03.031.
WANG J Z, CHEN J M, ZENG Z Y, et al. Effects of autophagy regulating drugs on proliferation, apoptosis and autophagy of multiple myeloma cells[J]. J Exp Hematol, 2018, 26(3): 817-823. DOI:10.7534/j.issn.1009-2137.2018.03.031.
[14]SKLIRIS A, LABROPOULOU V T, PAPACHRISTOU D J, et al. Cell-surface serglycin promotes adhesion of myeloma cells to collagen type I and affects the expression of matrix metalloproteinases[J]. FEBS J, 2013, 280(10): 2342-2352. DOI:10.1111/febs.12179.
[15]YANG G L, TAO H R, WANG H W, et al. Ara-C increases gastric cancer cell invasion by upregulating CD-147-MMP-2/MMP-9 via the ERK signaling pathway[J]. Oncol Rep, 2015, 33(4): 2045-2051. DOI:10.3892/or.2015.3748.
[16]CANO C E, HAMIDI T, GARCIA M N, et al. Genetic inactivation of Nupr1 Acts as a dominant suppressor event in a two-hit model of pancreatic carcinogenesis[J]. Gut, 2014, 63(6): 984-995. DOI:10.1136/gutjnl-2013-305221.
[17]HAMIDI T, ALGL H, CANO C E, et al. Nuclear protein 1 promotes pancreatic cancer development and protects cells from stress by inhibiting apoptosis[J]. J Clin Invest, 2012, 122(6): 2092-2103. DOI:10.1172/JCI60144.
[18]ZHANG L, WANG H D, ZHU J H, et al. Mollugin induces tumor cell apoptosis and autophagy via the PI3K/AKT/mTOR/p70S6K and ERK signaling pathways[J]. Biochem Biophys Res Commun, 2014, 450(1): 247-254. DOI:10.1016/j.bbrc.2014.05.101.
[19]TONG Y, ZHU W, HUANG X, et al. PI3K inhibitor LY294002 inhibits activation of the Akt/mTOR pathway induced by an oncolytic adenovirus expressing TRAIL and sensitizes multiple myeloma cells to the oncolytic virus[J]. Oncol Rep, 2014, 31(4): 1581-1588. DOI: 10.3892/or.2014.3020.
[20]HU J, HU W X. Targeting signaling pathways in multiple myeloma: Pathogenesis and implication for treatments[J]. Cancer Lett, 2018, 414: 214-221. DOI: 10.1016/j.canlet.2017.11.020.
[21]罗国平, 刘芬, 谷文, 等. 褐藻糖胶对U266细胞自噬、迁移及侵袭的影响[J]. 上海交通大学学报(医学版), 2017, 37(3): 312-317. DOI: 10.3969/j.issn.1674-8115.2017.03.007.
LUO G P, LIU F, GU W, et al. Effect of fucoidan on autophagy, migration and invasion of U266 cells[J]. J Shagnhai Jiaotong Univ(Med Sci), 2017, 37(3): 312-317. DOI: 10.3969/j.issn.1674-8115.2017.03.007.

相似文献/References:

[1]李佳丽,刘耀,曾东风,等.硼替佐米联合地塞米松和沙利度胺治疗多发性骨髓瘤的临床研究[J].第三军医大学学报,2012,34(24):2515.
 Li Jiali,Liu Yao,Zeng Dongfeng,et al.Bortezomib combined with dexamethasone and thalidomide in treatment of multiple myeloma: report of 58 cases[J].J Third Mil Med Univ,2012,34(23):2515.
[2]段海玲,熊玮,杨和平,等.误诊为肺癌骨转移的多发性骨髓瘤1例[J].第三军医大学学报,2008,30(10):931.
[3]杨再林,张勇,张伶,等.硼替佐米联合化疗对多发性骨髓瘤的疗效与相关血液学指标分析[J].第三军医大学学报,2010,32(09):975.
 Yang Zailin,Zhang Yong,Zhang Ling,et al.Effect of bortezomib in combination with chemotherapy on multiple myeloma and change in its hematological indexes[J].J Third Mil Med Univ,2010,32(23):975.
[4]张超,陈晓红.Syndecan-1在多发性骨髓瘤发病中作用的研究进展[J].第三军医大学学报,2005,27(18):1891.
[5]谢家印,王东,李梦侠,等.APE1/Ref-1 siRNA抑制多发性骨髓瘤骨髓基质细胞IL-6及IL-8分泌的体外研究[J].第三军医大学学报,2009,31(19):1850.
 XIE Jia-yin,WANG Dong,LI Meng-xia,et al.APE1/Ref-1 siRNA inhibits IL-6 and IL-8 secretion by cultured bone marrow stromal cells isolated from multiple myeloma patients[J].J Third Mil Med Univ,2009,31(23):1850.
[6]谢家印,杜佳,李梦侠,等.RNA干扰骨髓基质细胞和/或骨髓瘤细胞APE1表达对共培养骨髓瘤细胞增殖及凋亡的影响[J].第三军医大学学报,2011,33(10):1008.
 Xie Jiayin,Du Jia,Li Mengxia,et al.Effects of RNA interference inhibiting APE1 expression in bone marrow stromal cells and/or U266 cells on proliferation and apoptosis of co-cultured U266[J].J Third Mil Med Univ,2011,33(23):1008.
[7]高力,张曦,高蕾,等.不同来源基质细胞对骨髓瘤KM3细胞增殖和凋亡的影响[J].第三军医大学学报,2009,31(10):879.
 GAO Li,ZHANG Xi,GAO Lei,et al.Effect of stromal cells derived from different origins on proliferation and apoptosis of KM3 cells[J].J Third Mil Med Univ,2009,31(23):879.
[8]李颖,陈建斌,宋君君,等.甲基化修饰致PCDH10基因在多发性骨髓瘤中沉默[J].第三军医大学学报,2012,34(09):817.
 Li Ying,Chen Jianbin,Song Junjun,et al.Methylation induces protocadherin-10 silence in multiple myeloma[J].J Third Mil Med Univ,2012,34(23):817.
[9]侯慧明,张红宾,刘林.IgG型多发性骨髓瘤自体造血干细胞移植后复发合并急性淋巴细胞白血病1例[J].第三军医大学学报,2013,35(13):1361.
[10]张亮,杜佳,周立为,等.依布硒诱导多发性骨髓瘤细胞凋亡及其机制的研究[J].第三军医大学学报,2014,36(02):110.
 Zhang Liang,Du Jia,Zhou Liwei,et al.Ebselen induces apoptosis in human multiple myeloma cell line U226[J].J Third Mil Med Univ,2014,36(23):110.

更新日期/Last Update: 2019-12-09